Clinical trial
Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
NCT02874092 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 15, 2016
- Completion date
- June 19, 2019
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis